Variables | Control (n = 78) | Case (n = 26) | p-value |
---|---|---|---|
Age (yrs)/mean ± SD | 8.62 ± 3.61 | 9.88 ± 2.86 | 0.107 |
Sex | 1.000* | ||
Females/n (%) | 38 (48.7) | 12 (46.2) | |
Males/n (%) | 40 (51.3) | 14 (53.8) | |
Weight (Kg) /mean ± SD | 29.28 ± 11.21 | 30.19 ± 8.75 | 0.671 |
Height (m) /mean ± SD | 1.27 ± 0.22 | 1.35 ± 0.15 | 0.025 |
BMI(Kg/m2) /mean ± SD | 17.52 ± 1.84 | 16.16 ± 2.15 | 0.002 |
Lymphadenopathy | 0 (0.0) | 6 (23.1) | < 0.0001* |
Hepatomegaly | 0 (0.0) | 7 (26.9) | < 0.0001* |
Treatment | NA | ||
Newly diagnosed | – | 4 (15.4) | |
On treatment | – | 22 (84.6) | |
Induction | – | 7 (26.9) | NA |
Consolidation | – | 4 (15.4) | NA |
Maintenance | – | 11 (42.3) | NA |